Nucleotide-evoked relaxation of rat vas deferens -: a possible role for endogenous ATP released upon α1-adrenoceptor stimulation

被引:4
作者
Bültmann, R [1 ]
Starke, K [1 ]
机构
[1] Univ Freiburg, Inst Pharmakol, D-79104 Freiburg, Germany
关键词
vas deferens; rat; smooth muscle relaxation; co-transmission; ATP; P2; receptor; noradrenaline; alpha(1)-adrenoceptor;
D O I
10.1016/S0014-2999(01)01086-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The possibility was tested that endogenous ATP released upon alpha (1)-adrenoceptor activation causes relaxation of the rat vas deferens smooth muscle. ATP, 2-methylthio ATP and adenosine relaxed the vas deferens precontracted with 80 mM K+. The metabolically stable P2 receptor agonists alpha,beta -methylene ATP (alpha,beta -MeATP) and adenosine 5 ' -O-(2-thiodiphosphate) (ADP betaS) had little or no effect. The adenosine P1 receptor antagonist 8-(para-sulfophenyl)theophylline did not significantly affect the response to ATP. The P2 receptor antagonist reactive blue 2 markedly reduced the relaxation (by up to 73 %); suramin, pyridoxalphosphate-6-azophenyl-2 ' ,4 ' -disulphonic acid (PPADS) and acid blue 129 caused no change. ATP, but not (alpha,beta -MeATP, also attenuated contractions elicited by noradrenaline at resting tension; reactive blue 2 blocked the inhibitory effect of ATP. Reactive blue 2, by itself, enhanced the response to noradrenaline (by up to 36%); suramin, PPADS and acid blue 129 caused no change. In the presence of the ATP-degrading enzymes apyrase and nucleotide pyrophosphatase, the facilitatory effect of reactive blue 2 was lost. Apyrase, by itself, enhanced the response to noradrenaline (by 13%). The results indicate that endogenous ATP. released from rat vas deferens smooth muscle upon alpha (1)-adrenoceptor stimulation, causes relaxation. The site of action of ATP is not a typical smooth muscle P2Y receptor. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 35 条
[1]   ATP ACTIVATES P2X-CONTRACTING AND P2Y-RELAXING PURINOCEPTORS IN THE SMOOTH-MUSCLE OF MOUSE VAS-DEFERENS [J].
BOLAND, B ;
HIMPENS, B ;
VINCENT, MF ;
GILLIS, JM ;
CASTEELS, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :1152-1158
[2]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[3]  
BULTMANN R, 1994, BRIT J PHARMACOL, V112, P690
[4]  
BULTMANN R, 1994, BRIT J PHARMACOL, V113, P349
[5]  
Bültmann R, 1999, N-S ARCH PHARMACOL, V360, P196
[6]  
BULTMANN R, 1996, PHARMACOLOGY, V353, P445
[7]  
BURNSTOCK G, 1990, ARCH INT PHARMACOD T, V304, P7
[8]   PRESYNAPTIC INHIBITORY ACTIONS OF ADENINE-NUCLEOTIDES AND ADENOSINE ON NEUROTRANSMISSION IN RAT VAS-DEFERENS [J].
CLANACHAN, AS ;
JOHNS, A ;
PATON, DM .
NEUROSCIENCE, 1977, 2 (04) :597-602
[9]   DIFFERENT MECHANISMS OF ACTION OF AGENTS ACTING ON BETA-ADRENOCEPTORS IN BARIUM-STIMULATED AND ELECTRICALLY-STIMULATED RAT VAS-DEFERENS [J].
DIAZTOLEDO, A ;
JURKIEWICZ, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) :277-283
[10]   COMPARISON OF CONTRACTIONS OF THE SMOOTH-MUSCLE OF THE GUINEA-PIG VAS-DEFERENS INDUCED BY ATP AND RELATED NUCLEOTIDES [J].
FEDAN, JS ;
HOGABOOM, GK ;
WESTFALL, DP ;
ODONNELL, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (02) :193-204